NASDAQ · Biotechnology

OmniAb, Inc. (OABI) Stock

$4.79 +2.79% NASDAQ: OABI Healthcare

Valuation

MetricValue
Price$4.79
Market Cap$694.42M
P/E Ratio-13.53
P/B Ratio2.41
P/S Ratio18.37
EPS (TTM)$-0.57
52-Week High$5.43
52-Week Low$1.30
Dividend Yield0.00%

Financials & Margins

MetricValue
ROE-16.59%
ROA-15.25%
ROCE-17.48%
Gross Margin-373.68%
Operating Margin-378.95%
Net Margin-115.18%
Debt/Equity0.07
Current Ratio4.06

Annual Financials (USD)

Metric20212022202320242025
Revenue$35.0M$59.0M$34.0M$26.0M$19.0M
Operating Profit$-36.0M$-27.0M$-69.0M$-75.0M$-72.0M
Net Profit$-27.0M$-22.0M$-51.0M$-62.0M$-65.0M
EPS$-0.24$-0.26$-0.51$-0.61$-0.57
Op Margin-102.5%-45.1%-203.2%-282.3%-383.1%

Balance Sheet (USD)

Metric20212022202320242025
Total Assets$304.0M$421.0M$375.0M$326.0M$301.0M
Total Liabilities$70.0M$80.0M$61.0M$38.0M$34.0M
Cash$0$33.0M$16.0M$28.0M$26.0M
Borrowings$14.0M$26.0M$26.0M$23.0M$20.0M

Latest News

OmniAb to Report Second Quarter 2026 Financial Results on August 6 Business Wire · Jul 16, 2026 OmniAb Appoints Amechi Nwachuku as Chief Operating Officer MT Newswires · Jul 13, 2026 OmniAb Names Amechi Nwachuku Chief Operating Officer Business Wire · Jul 13, 2026 The Cancer Therapy Strategy VERAXA Is Betting the Company On Exec Edge · Jul 6, 2026 OmniAb (OABI) Gains More Than 38% Over 6 Months, Can It Go Higher? Insider Monkey · Jul 3, 2026

Cash Flow (USD)

Metric20212022202320242025
Operating Cash Flow$-6.0M$-4.0M$2.0M$-40.0M$-36.0M
Investing Cash Flow$-8.0M$-90.0M$-20.0M$36.0M$6.0M
Financing Cash Flow$10.0M$14.0M$-1.0M$2.0M$0
Net Cash Flow$0$33.0M$-17.0M$11.0M$-2.0M
Free Cash Flow$-10.0M$-21.0M$1.0M$-42.0M$-37.0M

Valuation & Return Ratios

MetricValue
PEG Ratio-0.26
EV / EBITDA-27.52
FCF Yield-2.57%
Quick Ratio4.80
Interest Coverage0.00
Return 1Y-5.12%
Return 3Y-61.65%
Return 5Y—

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
AAPLApple Inc. $336.64 -1.11% 38.93 $4.94T 0.32%
MSFTMicrosoft Corporation $535.07 +2.38% 28.68 $3.97T 0.76%
GOOGLAlphabet Inc. $351.66 +0.97% 16.94 $4.26T 0.26%
AMZNAmazon.com, Inc. $262.43 +3.29% 19.82 $2.82T 0.00%
METAMeta Platforms, Inc. $718.67 -0.31% 27.93 $1.83T 0.28%

About OmniAb, Inc.

OmniAb, Inc. is led by CEO Matthew W. Foehr, employs 114 people, headquartered in US, publicly traded since 2021.

OmniAb, Inc. (OABI) stock trades at $4.79 with a market capitalization of $694.42M. The stock is valued at a price-to-earnings (P/E) ratio of -13.53, price-to-book of 2.41, price-to-sales of 18.37. Over the past 52 weeks the stock has ranged between $1.30 and $5.43, and currently trades 11.8% below its 52-week high.

On profitability, OmniAb, Inc. generates a return on equity (ROE) of -16.59%, return on capital employed of -17.48%, an operating margin of -378.95%, a net profit margin of -115.18%.

Related Healthcare Stocks

LLY Eli Lilly and Company $1179.27 +0.83% JNJ Johnson & Johnson $261.44 +1.93% ABBV AbbVie Inc. $276.47 +1.49% MRK Merck & Company, Inc. Common Stock (new) $145.60 +2.26% UNH UnitedHealth Group Incorporated Common Stock (DE) $379.30 +2.25% NVS Novartis AG $143.75 +0.45% AZN AstraZeneca PLC $159.20 +0.26% TMO Thermo Fisher Scientific Inc $658.02 +0.93% AMGN Amgen Inc. $414.87 +1.82% GILD Gilead Sciences, Inc. $151.17 +2.77% ABT Abbott Laboratories $99.60 +1.13% NVO Novo Nordisk A/S $38.64 +1.20%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksNasdaq High ROE StocksAll stock screens
Run Stock Screener Investing Guides